Diplomat Pharmacy hosts college students as part of Alternative Spring Break program
FLINT, Mich. — Diplomat Pharmacy on Friday announced it will be hosting college students from across the nation this week. Students from as far away as New Mexico State will be participating in an expanded version of Diplomat’s Alternative Spring Break program that kicked off Monday.
Also serving with New Mexico State will be students and staff members from Michigan State, Virginia Tech and the University of Michigan-Ann Arbor.
Alternative Spring Break is a nationwide program that offers community service-learning experiences during the traditional college spring breaks, according to Steve Wolbert, Diplomat’s director of community relations and government affairs. The students have spent months learning about the culture and history of Flint, and once they arrive, they will be immersed in the community with experiential learning opportunities and direct service to non-profits.
The program also includes group discussions, readings and reflection activities at a selected site to engage in meaningful action toward a greater understanding of root causes of relevant issues.
Diplomat is the primary facilitator between the students and various community organizations in the Flint area. Wolbert said that as they enter the fifth year of the program, they continue to look for key indicators that the program is successful.
Activities for their respective weeks in Flint will include city tours; working with Genesee County Habitat for Humanity, Carriage Town Mission, St. Luke N.E.W. Life Center, North End Soup Kitchen and Boys & Girls Club of Greater Flint; and assisting Kettering University with a neighborhood cleanup of the Mott Park area. Each morning students will work with various community organizations in the Flint area. Afternoons will be spent volunteering at local schools working and tutoring students. ASB students will hear from local community leaders from the non-profit, government and business sector during dinner each evening.
Bydureon pen gets FDA approval
WILMINGTON, Del. — AstraZeneca received approval from the Food and Drug Administration for its Bydureon pen (exenatide extended-release for injectable suspension) 2-mg, which is to be used as an addition to diet and exercise to improve glycemic control in adults with Type 2 diabetes.
The Bydureon pen is a pre-filled, single-use pen injector, which eliminates the need for the patient to transfer their medication between a vial and syringe during the process of self-injection. The pen contains the same formula and dose as the original Bydureon single-dose tray.
“We are pleased to receive approval for the Bydureon Pen, which can provide a powerful reduction in blood glucose levels along with the potential benefit of weight loss, through a once-weekly dose in a pre-filled device,” said Briggs Morrison, M.D., EVP of global medicines development and chief medical officer for AstraZeneca. “We are committed to addressing the needs of adults with Type 2 diabetes, including ongoing research to develop new treatments and methods of delivery.”
AstraZeneca said it plans to make the pen available for patients later this year. The single-dose tray will remain on the market for patients prescribed Bydureon.
Cardinal Health Specialty Solutions acquires Sonexus Health
DUBLIN, Ohio — Cardinal Health Specialty Solutions on Monday announced the acquisition of privately held Sonexus Health, a Dallas-based company that offers a range of patient access and specialty commercialization services.
“The addition of Sonexus Health to our portfolio brings us even closer to the patient by enabling us to provide a next generation solution to help clients ensure that patients who need specialty medications can get faster access to them and the right services to improve clinical outcomes,” said Scott Howell, SVP clinical affairs for Cardinal Health Specialty Solutions. “Our combined core competencies further strengthen our efforts to help payors, physician practices and biopharmaceutical manufacturers navigate the growing complexity of specialty care.”
Cardinal Health Specialty Solutions clients will now have access to Sonexus Health’s patient services "hub," which serves as a patient and physician practice support center that:
- Reduces administrative burdens by working with patients, physician offices and insurance companies to facilitate treatment coverage and coordinate the medication reimbursement process;
- Improves patient access by identifying appropriate copay assistance and free-drug programs that can make specialty medications more affordable;
- Also improves patient access by delivering medications — based on manufacturer guidelines — with efficiency and supply chain integrity; and
- Helps improve patient outcomes by delivering disease education and medication compliance programs.
In addition, Cardinal Health Specialty Solutions clients will have access to expanded third-party logistics services, enabling them to send higher volumes of smaller parcel shipments directly to physician offices, clinics and hospitals.
The base of Sonexus Health’s operations will remain in Dallas, and customers will continue to be served in the same service model currently offered.